期刊文献+

PPARγ基因表达对子宫内膜癌细胞迁移、侵袭及增殖能力的影响 被引量:5

Effects of PPARγ gene expression on cell migration, invasion, and proliferation in endometrial cancer cells
原文传递
导出
摘要 目的 探讨过氧化物酶增殖体激活受体γ(PPARγ)基因表达对子宫内膜癌细胞迁移、侵袭及增殖能力的影响.方法 选取子宫内膜癌细胞系ECC-1(ER阳性)及KLE(ER阴性)细胞,分别转染PPARγ基因表达载体(PPARγ载体组)及PPARγ小分子干扰RNA(siRNA)质粒(PPARγsiRNA组),以转染无义序列siRNA(siRNA无义序列组)、空载体(空载体组)者为阴性对照,以只加入脂质体者(空白对照组)为空白对照.转染48 h后,实时逆转录(RT)-PCR技术及蛋白印迹法(western blot)检测细胞中PPARγmRNA及蛋白表达水平的变化;western blot检测细胞中Wnt信号传导通路中关键蛋白——β连接素(β-catenin)及髓细胞增生原癌基因编码蛋白(C-myc)蛋白表达水平的变化;体外迁移、侵袭实验检测细胞迁移、侵袭能力的变化,活细胞计数(CCK-8)法检测细胞增殖能力[以吸光度(A)值表示].结果 转染48 h后,实时RT-PCR技术和western blot检测显示,PPARγ载体组ECC-1及KLE细胞中PPARγ mRNA(分别为5.18 ±0.99、4.54±0.89)和蛋白(分别为1.45±0.12、1.30±0.13)的表达水平升高,β-eatenin(分别为0.44 ±0.06、0.46±0.04)、C-myc(分别为0.42±0.08、0.30±0.11)蛋白表达水平降低,PPAR γ siRNA组ECC-1及KLE细胞中PPAR γ mRNA(分别为0.48 ±0.08、0.53±0.11)和蛋白(分别为0.41±0.04、0.49±0.05)的表达水平降低,β-catenin(分别为1.18±0.12、0.89±0.07)、C-myc(分别为0.91 ±0.08、0.77 ±0.12)蛋白的表达水平升高,分别与siRNA无义序列组、空载体组、空白对照组比较,差异均有统计学意义(P<0.05).体外迁移、侵袭实验检测显示,PPAR γ载体组ECC-1、KLE细胞的迁移细胞数[分别为(129±9)、(119±9)个]及侵袭细胞数[分别为(63±12)、(68±16)个]减少,PPARγ siRNA组ECC-1、KLE细胞的迁移细胞数[分别为(201±14)、(170±11)个]及侵袭细胞数[分别为(142±9)、(138±7)个]增多,分别与siRNA无义序列组、空载体组、空白对照组比较,差异均有统计学意义(P<0.05).CCK-8法检测显示,PPARγ载体组ECC-1、KLE细胞的A值(分别为0.66±0.14、0.78 ±0.06)均低于siRNA无义序列组、空载体组、空白对照组,PPARγ siRNA组ECC-1、KLE细胞的A值(分别为1.42±0.16、1.23±0.04)均高于siRNA无义序列组、空载体组、空白对照组,分别比较,差异均有统计学意义(P<0.05).结论 上调PPARγ基因表达可抑制子宫内膜癌细胞的迁移、侵袭及增殖,而下调PPARγ基因表达可促进子宫内膜癌细胞的迁移、侵袭及增殖. Objective To observe the effects of differentially expressed peroxisome proliferatoractivated receptor γ (PPAR γ) on cell migration,invasion and proliferation of endometrial cancer cells.Methods Two endometrial cancer cell lines ECC-1 (ER positive) and KLE (ER negative) cells were used in this study.To up or down regulate PPARγ expression,the transient transfection by using PPARγ expression vector (PPARγ expression vector group) and PPARγ small interference RNA (PPARγ siRNA group) were done.The negative control groups were cells transfected by nonsence sequence siRNA (siRNA non sence sequence group) or empty vector (empty vector group).At the same time,cells only added with liposome were used as blank control group.Then,quantitative real time (RT)-PCR and western blot were used to detect PPARγexpression both in mRNA and protein levels.To assess the expression levels of Wnt signaling pathway,western blot was performed to analysis protein levels of β-catenin and C-myc.The effects on cell migration,invasion and proliferation using in vitro transwell migration,invasion assays and cell counting kit-8 (CCK-8) assay were further be examined.Results After transfection for 48 hours,quantitative RT-PCR and western blot showed that PPARγmRNA (5.18 ± 0.99,4.54 ± 0.89) and protein (1.45 ± 0.12,1.30 ± 0.13) expression levels significantly increased and the protein levels of β-catenin (0.44 ± 0.06,0.46 ± 0.04) and C-myc (0.42 ± 0.08,0.30 ± 0.11) decreased in PPAR γ expression vector group,while in PPARγ siRNA group,PPARγ mRNA (0.48 ± 0.08,0.53 ± 0.11) and protein (0.41 ±0.04,0.49 ±0.05) expression levels decreased and the protein levels of 3-catenin (1.18 ±0.12,0.89 ±0.07) and C-myc(0.91 ±0.08,0.77 ±0.12) increased significantly compared with control groups (all P 〈 0.05).In vitro migration and invasion assay indicated that the migratory and invasive cell numbers of PPARγ expression vector group (ECC-1:129 ± 9,63 ± 12 ; KLE:119 ± 9,68 ± 16) were significantly decreased,while the migratory and invasive cell numbers of were PPARγ siRNA group (ECC-1:201 ± 14,142 ±9 ; KLE:170 ± 11,138 ± 7) increased significantly compared with those in control groups(all P 〈 0.05).CCK-8 assay showed that A values (0.66 ±0.14,0.78 ±0.06) in PPARγexpression vector group were lower than those in control groups,and in PPARγ siRNA group,A values (1.42 ± 0.16,1.23 ± 0.04) were higher than those in control groups,and there were statistically significant difference among them (all P 〈 0.05).Conclusion Up-regulated PPARγ gene expression could inhibit endometrial cancer cell migration,invasion and proliferation abilities,and down-regulated PPARγ gene expression could promote endometrial cancer cell migration,invasion and proliferation abilities.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2014年第5期360-365,共6页 Chinese Journal of Obstetrics and Gynecology
基金 山东省自然科学基金(ZR2010HM102)
关键词 子宫内膜肿瘤 PPARΓ 细胞运动 肿瘤侵润 细胞增殖 Endometrial neoplasms PPAR gamma Cell movement Neoplasm invasiveness Cell proliferation
  • 相关文献

参考文献18

  • 1Boll D, Karim-Kos HE, Verhoevcn RH, et al. Increased incidence and improved survival in endometrioid endometrial cancer diagnosed since 1989 in the Netherlands: a population based study[ J]. Eur J Obstet Gynecol Reprod Biol, 2013, 166: 209-214.
  • 2Arora V, Quinn MA. Endometrial cancer[J]. Best Pract Res Clin Obstet Gynaecol, 2012, 26:311-324.
  • 3Jay MA, Ren J. Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus[J]. Curt" Diabetes Rev, 2007, 3:33-39.
  • 4Mo B, Vendrov AE, Palomino WA, et al. ECC-1 ceils: a well- differentiated steroid-responsive endometrial cell line with characteristics of luminal epithelium[ J]. Biol Reprod, 2006, 75 : 387-394.
  • 5Wei Y, Zhang Z, Liao H, et al. Nuclear estrogen receptor- mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation [J]. Oncol Rep, 2012, 27:504-510.
  • 6Reka AK, Kurapati H, Narala VR, et al. Peroxisome proliferator- activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition [J]. Mol Cancer Ther, 2010, 9:3221-3232.
  • 7Robbins GT, Nie D. PPAR gamma, bioactive lipids, and cancer progression[ J]. Front Biosci ( Landmark Ed), 2012, 17 : 1816- 1834.
  • 8Tsukahara T, Haniu H. Peroxisome proliferator-activated receptor gamma overexpression suppresses proliferation of human colon cancer cells [ J ]. Biochem Biophys Res Commun, 2012, 424 : 524-529.
  • 9江颖,邹琳,张春晖,陆维祺,朱隽,罗文杰,张华,沈爱国.乳腺癌中过氧化物酶体增殖激活受体γ和β-连环蛋白表达及临床意义[J].中华实验外科杂志,2010,27(6):699-701. 被引量:4
  • 10Reka AK, Goswami MT, Krishnapuram R, et al. Molecular cross- regulation between PPAR-/ and other signaling pathways: implications for lung cancer therapy[ J]. Lung Cancer, 2011,72 : 154-159.

二级参考文献6

  • 1杨维良,张东伟.乳腺癌基因治疗的研究现状及展望[J].中华实验外科杂志,2005,22(5):633-635. 被引量:15
  • 2王深明.乳腺外科实验研究的发展方向[J].中华实验外科杂志,2006,23(5):519-521. 被引量:5
  • 3Krishnan A,Nair SA,Pillai MR.Biology of PPAR gamma in cancer:a critical review on existing lacunae.Curr Mol Med,2007,7:532-540.
  • 4Xiong X,Ye Y,Fu L,et al.Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR ganma agonists against a panel of human cancer cell lines.Invest New Drugs,2009,27:223-232.
  • 5Nú(n)ez NP,Liu H,Meadows GG.PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma,prostate,and breast cancer cells.Cancer Lett,2006,236:133-141.
  • 6Lin SY,Xia W,Wang JC,et al.Beta-catenin,a novel prognostic marker for breast cancer:its roles in Cyclin D1 expression and cancer progression.Proc Natl Acad Sci USA,2000,97:4262-4266.

共引文献3

同被引文献28

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部